Long-acting multipurpose prevention technology (MPT) implants to prevent HIV & unintended pregnancy
Thursday, July 17, 2025
11:49 AM – 12:00 PM EDT
Introduction: MPTs synergize prevention approaches by combining protection against HIV and unintended pregnancies and can improve health outcomes by providing singular products that simplify use, lower burden, and have higher acceptability.(1) We developed a biodegradable MPT implant that sustainably releases an antiretroviral, islatravir (ISL), and a contraceptive hormone, etonogestrel (ENG). With simultaneous release of ISL and ENG from a single rod that is compatible with market-available trocars, we present an innovative strategy to address women’s overlapping sexual and reproductive health risks.
Learning Objectives:
At the completion of this activity, participants will know
Learn about a long-acting biodegradable implant that delivers an antiretroviral and a contraceptive.
The single-rod multi-prevention implant strategy simplifies administration and improves adherence.
